Stock Groups

GSK improves profit outlook after Q3 beats expectations -Breaking

by Mike Robinson

[ad_1]

© Reuters. FILEPHOTO: The logo for GlaxoSmithKline pharmaceutical company can be seen in their Stevenage, UK facility on October 26, 2020. REUTERS/Matthew Childs/File Photograph GLOBAL WEEK Ahead

(Reuters) – GSK, Britain’s largest pharmaceutical company beat analyst expectations on Wednesday for its third quarter earnings and increased its outlook for next year’s profit in advance of a planned division.

According to the company, 2021 adjusted earnings per stock will fall between 2% and 4.4% at constant currency rates. This excludes any COVID-19 boosts. The company had previously forecast that profit would fall in the single-digits to mid-to high range.

Disclaimer Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are provided by market makers and are therefore not necessarily accurate. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.



[ad_2]